Cucchi Alessandro, Cova Marisa, Merciadri Giovanni Vasco, Serenelli Carlotta, Ghiselli Giuseppina, Buriani Orazio, Gabutti Giovanni
Dipartimento di Medicina Clinica e Sperimentale, Sezione di Igiene e Medicina del Lavoro, Università di Ferrara.
Ig Sanita Pubbl. 2010 Jul-Aug;66(4):409-18.
A questionnaire study was performed amongst subjects travelling to high-risk areas for traveller's diarrhoea and who had been prescribed the oral cholera vaccine Dukoral. The study was performed in 2006 at two travel medicine centres in northern Italy. One-hundred subjects participated in the study and completed the questionnaire. Compliance with the vaccine was very good (83.2%) and no serious adverse reactions were reported. 14.3% of vaccinated subjects reported diarrhoea.
在前往旅行者腹泻高风险地区且已接种口服霍乱疫苗“度可罗”(Dukoral)的受试者中开展了一项问卷调查研究。该研究于2006年在意大利北部的两个旅行医学中心进行。100名受试者参与了研究并完成了问卷。疫苗的依从性非常好(83.2%),且未报告严重不良反应。14.3%的接种疫苗受试者报告有腹泻症状。